12 Analysts Have This to Say About Stoke Therapeutics
Portfolio Pulse from Benzinga Insights
In the last 3 months, 12 analysts have provided 12-month price targets for Stoke Therapeutics (NASDAQ:STOK), with an average price target of $25.17, up 7.11% from the previous average of $23.50. The ratings include 6 bullish, 5 somewhat bullish, and 1 indifferent.
May 23, 2023 | 8:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Stoke Therapeutics (STOK) has received positive analyst ratings in the last 3 months, with an average 12-month price target of $25.17, up 7.11% from the previous average.
The article mentions that Stoke Therapeutics (STOK) has received positive analyst ratings in the last 3 months, with 6 bullish, 5 somewhat bullish, and 1 indifferent rating. The average 12-month price target has increased by 7.11% from the previous average, indicating a positive outlook for the stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100